Safety

GLP-1 Medications, Surgery, and Anesthesia

Creator: Weight Reset Guide Editorial Team
Published: 2026-09-27

A plain-English, source-backed guide to GLP-1 medicines before surgery and anesthesia: why anesthesiology guidance focuses on delayed stomach emptying and aspiration risk, what the ASA task force suggests for elective procedures, what to tell your surgical and prescribing teams, and which decisions belong with clinicians.

By Weight Reset Guide Editorial Team | Published 2026-09-27 | Editorially reviewed for clarity and source alignment

Answer snapshot

Topic	Safety
Plain-English answer	GLP-1 medicines can slow stomach emptying, which anesthesiology guidance links to a higher chance that stomach contents come up into the lungs during general anesthesia or deep sedation. The ASA task force suggests considering holding daily doses on the day of an elective procedure and weekly doses about a week before, and delaying if stomach symptoms are present.
Best next step	Use this information to prepare questions for a licensed clinician or to compare a program's process, costs, safety policy, and follow-up.
Important boundary	This page cannot decide personal eligibility, medication choice, dosing, pharmacy source, insurance coverage, or medical safety.
Source types used	American Society of Anesthesiologists, MedlinePlus, MedlinePlus Medical Encyclopedia, NIDDK, MedlinePlus

A safety checklist showing clinician screening, medication source, side effects, and follow-up — A responsible program should make safety, source, and follow-up easy to understand.

Key takeaways

The ASA task force writes that GLP-1 receptor agonists are approved by the FDA for type 2 diabetes and for cardiovascular risk reduction in that group, that they are also used for weight loss, and that its suggestions apply irrespective of the indication, the dose, or the type of procedure or surgery.
The ASA guidance states that GLP-1 agonists are associated with gastrointestinal effects such as nausea, vomiting, and delayed gastric emptying, and that the effects on gastric emptying are reported to be reduced with long-term use.
The ASA task force explains that there are concerns that delayed gastric emptying from GLP-1 agonists can increase the risk of regurgitation and pulmonary aspiration of gastric contents during general anesthesia and deep sedation.
The ASA guidance notes that stomach symptoms such as nausea, vomiting, dyspepsia, and abdominal distension in people taking GLP-1 agonists are predictive of increased residual gastric contents.
For elective procedures, the ASA task force suggests considering holding GLP-1 agonists on the day of the procedure for daily dosing and a week prior for weekly dosing, and considering delaying the procedure if gastrointestinal symptoms such as severe nausea, vomiting, retching, abdominal bloating, or abdominal pain are present.
MedlinePlus advises telling your surgeon or nurse about every medicine, supplement, or herb you take before surgery, and states that general anesthesia is generally safe but carries risks such as breathing problems, heart rhythm problems, and allergic reactions.

Why surgery and anesthesia come up in a weight-care conversation

Most medical weight-care questions are about eligibility, cost, side effects, and follow-up. A planned procedure adds a different question to the list: what does the team giving anesthesia need to know about the medicines you take.

This is not a rare overlap. NIDDK notes that weight-loss surgery is usually performed laparoscopically, with small cuts made under general anesthesia, and MedlinePlus describes general anesthesia as the type used during major surgeries. Any procedure that uses sedation, not only weight-related surgery, sits in the same territory.

The American Society of Anesthesiologists (ASA) addresses the question directly. Its Task Force on Preoperative Fasting published consensus-based guidance on the preoperative management of patients on GLP-1 receptor agonists, and it states that its suggestions apply irrespective of whether the medicine is used for type 2 diabetes or for weight loss, irrespective of dose, and irrespective of the type of procedure or surgery.

This page stays in the education lane. It summarizes what the guidance and the federal health sources say in plain English so you can prepare better questions, and it does not tell anyone whether to stop, pause, or continue a prescribed medicine.

What the anesthesiology guidance says about GLP-1 medicines

The ASA task force writes that GLP-1 receptor agonists are approved by the FDA for the treatment of type 2 diabetes and for cardiovascular risk reduction in that group, and that they are also used for weight loss. It records that several entities have recommended holding these drugs either the day before or the day of the procedure, and that for patients on weekly dosing it is recommended to hold the dose for a week.

The guidance then explains the mechanism behind that advice. GLP-1 agonists are associated with adverse gastrointestinal effects such as nausea, vomiting, and delayed gastric emptying, and the effects on gastric emptying are reported to be reduced with long-term use, most likely through rapid tachyphylaxis at the level of vagal nerve activation.

It states that, based on recent anecdotal reports, there are concerns that delayed gastric emptying from GLP-1 agonists can increase the risk of regurgitation and pulmonary aspiration of gastric contents during general anesthesia and deep sedation. It adds that adverse gastrointestinal symptoms such as nausea, vomiting, dyspepsia, and abdominal distension in patients taking GLP-1 agonists are predictive of increased residual gastric contents.

The task force also notes that the evidence available to guide preoperative management is sparse and limited to several case reports, and that its suggestions therefore rest on the concern about delayed gastric emptying and aspiration risk rather than on large trials. It states that GLP-1 use in children is mainly reported for type 2 diabetes and obesity, that published pediatric literature comes mostly from patients 10 to 18 years old, and that concerns are similar to those in adults.

What delayed stomach emptying means for anesthesia risk

NIDDK describes gastroparesis, also called delayed gastric emptying, as a disorder that slows or stops the movement of food from your stomach to your small intestine, even though there is no blockage in the stomach or intestines. NIDDK lists symptoms such as feeling full shortly after starting a meal, feeling full long after eating a meal, nausea, and vomiting.

That is the picture the anesthesia concern is built on. If food and fluid stay in the stomach longer, the stomach holds more content at the moment sedation or general anesthesia begins, and the ASA guidance treats that as a reason to be cautious about stomach contents coming up and being inhaled into the lungs.

MedlinePlus describes general anesthesia as medicines that put you into a deep sleep-like state so you do not feel pain during surgery, and it notes that once you are asleep the doctor may insert a tube into your windpipe to help you breathe and protect your lungs. It also states that anesthesia is generally safe but that risks exist, especially with general anesthesia, including heart rhythm problems, breathing problems, an allergic reaction to the anesthesia, temporary confusion, and, rarely, awareness during general anesthesia.

None of this means that a person on a GLP-1 medicine will have a problem during a procedure. It means the risk question is real enough that anesthesia teams now ask about these medicines, and that the answer belongs in a conversation between the patient and the clinicians involved.

What the task force suggests for elective procedures

For patients scheduled for elective procedures, the ASA task force suggests considering the following. On the days prior to the procedure, for patients on daily dosing it suggests considering holding GLP-1 agonists on the day of the procedure or surgery, and for patients on weekly dosing it suggests considering holding them a week prior to the procedure or surgery.

On the day of the procedure, it suggests considering delaying an elective procedure if gastrointestinal symptoms such as severe nausea, vomiting, retching, abdominal bloating, or abdominal pain are present, and discussing the potential risk of regurgitation and pulmonary aspiration of gastric contents with the proceduralist or surgeon and the patient.

If the patient has no gastrointestinal symptoms but the GLP-1 agonist was not held as advised, the guidance suggests proceeding with full stomach precautions or considering evaluating gastric volume by ultrasound, if that is possible and the clinician is proficient with the technique. If the stomach is empty, it suggests proceeding as usual. If the stomach is full, or if gastric ultrasound is inconclusive or not possible, it suggests considering delaying the procedure or treating the patient as a full stomach.

For patients requiring urgent or emergent procedures, the task force suggests proceeding and treating the patient as a full stomach and managing accordingly. The document frames all of this as guidance for clinical teams, not as instructions for patients to apply on their own.

What to tell your surgical, anesthesia, and prescribing teams

MedlinePlus gives clear directions for the days around a procedure. It states that you should tell your surgeon or nurse if you are or could be pregnant and if you are taking any medicines, including drugs, supplements, or herbs you bought without a prescription.

It also states that during the week before surgery you may be asked to temporarily stop taking medicines that keep your blood from clotting, called blood thinners, including over-the-counter medicines and supplements such as aspirin, ibuprofen, naproxen, and vitamin E, and that many prescription medicines are blood thinners too. It advises asking your surgeon which medicines you should still take on the day of surgery, following instructions about when to stop eating and drinking, taking the medicines your surgeon told you to take with a small sip of water, and arriving on time.

The Medical Encyclopedia entry on general anesthesia lists situations that may raise the risk of problems with general anesthesia, including using large amounts of alcohol or medicines such as sedatives, opioids, or illicit drugs; having allergies or a family history of being allergic to medicines; having heart, lung, or kidney problems; and smoking. It states that general anesthesia is usually safe for healthy people and that most people recover completely.

For the medication itself, the practical step is a three-way conversation. Tell the surgical or anesthesia team that you take a GLP-1 medicine, tell your prescribing clinician that a procedure is scheduled, and ask who is responsible for the decision about holding or continuing the medicine. MedlinePlus notes that your overall health, medical history, the procedure you are having, and other factors help determine the type of anesthesia you receive, which is another reason the plan is made person by person.

Questions to bring to your care team

A short list makes the conversation easier. Which medicine am I taking, and is it daily or weekly dosing? Does the anesthesia team for this procedure want it held, and if so, for how long? Who will decide that, and how do I reach them if the procedure date changes?

Also ask what to do about stomach symptoms. Have I had nausea, vomiting, retching, bloating, or abdominal pain recently, and does that change the plan? What happens if I am unable to hold the medicine as advised? What should I do if my procedure becomes urgent or emergent?

Finally, bring the medication list itself. Include prescription medicines, over-the-counter products, supplements, and herbs, and note any that affect clotting. MedlinePlus advises telling your care team about everything you take, including products bought without a prescription, and following your surgeon's instructions on eating, drinking, and which medicines to take on the day of the procedure.

What this page can and cannot do

This page can help you understand terms and prepare better questions. It cannot tell you whether a medication, program, dose, or pharmacy is appropriate for you. Talk with a licensed clinician for personal medical advice.

Practical checklist

Before you decide	What to verify
Clinical fit	Ask which health-history factors could make a medical weight-care option appropriate or inappropriate.
Cost	Separate visit fees, lab fees, medication cost, subscription fees, pharmacy charges, and cancellation terms.
Medication source	Ask what pharmacy is used and whether the product is FDA-approved or compounded.
Follow-up	Confirm how side effects, dose questions, refills, and urgent concerns are handled.

Common questions table

Question	Short answer
Should I stop my GLP-1 medicine before surgery?	That decision belongs to your prescribing clinician and the surgical and anesthesia teams. The ASA task force suggests considering holding GLP-1 agonists on the day of an elective procedure for daily dosing and a week prior for weekly dosing, and considering delaying an elective procedure if gastrointestinal symptoms such as severe nausea, vomiting, retching, abdominal bloating, or abdominal pain are present. Do not stop or change a prescribed medicine on your own; ask your care team first.
Why does the anesthesia team ask about GLP-1 medicines?	The ASA guidance explains that GLP-1 agonists are associated with delayed gastric emptying and that there are concerns this can increase the risk of regurgitation and pulmonary aspiration of gastric contents during general anesthesia and deep sedation. It notes that the evidence to guide preoperative management is sparse and limited to case reports.
What is delayed gastric emptying?	NIDDK describes gastroparesis, also called delayed gastric emptying, as a disorder that slows or stops the movement of food from your stomach to your small intestine, even though there is no blockage. Symptoms it lists include feeling full shortly after starting a meal, feeling full long after eating a meal, nausea, and vomiting.
What if I have stomach symptoms on the day of my procedure?	The ASA task force suggests considering delaying an elective procedure when gastrointestinal symptoms such as severe nausea, vomiting, retching, abdominal bloating, or abdominal pain are present, and discussing the potential risk of regurgitation and pulmonary aspiration with the proceduralist or surgeon and the patient. Tell the team about your symptoms rather than deciding by yourself.
What happens if my procedure is urgent or emergent?	For patients requiring urgent or emergent procedures, the ASA task force suggests proceeding and treating the patient as a full stomach and managing accordingly. That is a clinical decision made by the treating team rather than something a patient applies from a website.
What should I tell my surgeon before surgery?	MedlinePlus states that you should tell your surgeon or nurse if you are or could be pregnant and if you are taking any medicines, including drugs, supplements, or herbs you bought without a prescription. It also states that you may be asked to temporarily stop blood thinners in the week before surgery, that you should ask your surgeon which medicines to take on the day of surgery, and that you should follow instructions about when to stop eating and drinking.
Is general anesthesia safe?	MedlinePlus states that anesthesia is generally safe but that there can be risks, especially with general anesthesia, including heart rhythm problems, breathing problems, an allergic reaction to the anesthesia, temporary confusion, and rarely awareness during general anesthesia. The Medical Encyclopedia states that general anesthesia is usually safe for healthy people and that most people recover completely, and it lists factors that may raise risk, such as heavy alcohol use, sedatives, opioids, or illicit drugs, medicine allergies, heart, lung, or kidney problems, and smoking. Ask your health care provider about the benefits and risks for you.

Quick questions

Should I stop my GLP-1 medicine before surgery?

That decision belongs to your prescribing clinician and the surgical and anesthesia teams. The ASA task force suggests considering holding GLP-1 agonists on the day of an elective procedure for daily dosing and a week prior for weekly dosing, and considering delaying an elective procedure if gastrointestinal symptoms such as severe nausea, vomiting, retching, abdominal bloating, or abdominal pain are present. Do not stop or change a prescribed medicine on your own; ask your care team first.

Why does the anesthesia team ask about GLP-1 medicines?

The ASA guidance explains that GLP-1 agonists are associated with delayed gastric emptying and that there are concerns this can increase the risk of regurgitation and pulmonary aspiration of gastric contents during general anesthesia and deep sedation. It notes that the evidence to guide preoperative management is sparse and limited to case reports.

What is delayed gastric emptying?

NIDDK describes gastroparesis, also called delayed gastric emptying, as a disorder that slows or stops the movement of food from your stomach to your small intestine, even though there is no blockage. Symptoms it lists include feeling full shortly after starting a meal, feeling full long after eating a meal, nausea, and vomiting.

What if I have stomach symptoms on the day of my procedure?

The ASA task force suggests considering delaying an elective procedure when gastrointestinal symptoms such as severe nausea, vomiting, retching, abdominal bloating, or abdominal pain are present, and discussing the potential risk of regurgitation and pulmonary aspiration with the proceduralist or surgeon and the patient. Tell the team about your symptoms rather than deciding by yourself.

What happens if my procedure is urgent or emergent?

For patients requiring urgent or emergent procedures, the ASA task force suggests proceeding and treating the patient as a full stomach and managing accordingly. That is a clinical decision made by the treating team rather than something a patient applies from a website.

What should I tell my surgeon before surgery?

MedlinePlus states that you should tell your surgeon or nurse if you are or could be pregnant and if you are taking any medicines, including drugs, supplements, or herbs you bought without a prescription. It also states that you may be asked to temporarily stop blood thinners in the week before surgery, that you should ask your surgeon which medicines to take on the day of surgery, and that you should follow instructions about when to stop eating and drinking.

Is general anesthesia safe?

MedlinePlus states that anesthesia is generally safe but that there can be risks, especially with general anesthesia, including heart rhythm problems, breathing problems, an allergic reaction to the anesthesia, temporary confusion, and rarely awareness during general anesthesia. The Medical Encyclopedia states that general anesthesia is usually safe for healthy people and that most people recover completely, and it lists factors that may raise risk, such as heavy alcohol use, sedatives, opioids, or illicit drugs, medicine allergies, heart, lung, or kidney problems, and smoking. Ask your health care provider about the benefits and risks for you.

Key terms on this page

unsafe offers, counterfeit risk, licensed clinician, pharmacy verification, side effects, urgent symptoms